Atai stock forecast.

Find the latest ATAI Life Sciences N.V. ATAI analyst stock forecast, price target, and recommendation trends with in-depth analysis from research reports. Date Range. investment rating. 24. 3. 2023. ... ... predictions of future events. Although we believe that the ... Total stockholders' equity attributable to ATAI Life Sciences N.V. stockholders ...NEW YORK and BERLIN, Jan. 06, 2023 (GLOBE NEWSWIRE) -- atai Life Sciences (NASDAQ: ATAI) (“atai” or “the Company”), a clinical-stage biopharmaceutical company focused on mental health ...Weather forecasts play an essential role in our daily lives, helping us plan our activities and stay prepared for any weather conditions that may come our way. One of the most common types of forecasts is the 7-day weather forecast, which p...

Get the latest ATAI Life Sciences NV (ATAI) real-time quote, historical performance, charts, and other financial information to help you make more informed ...ATAI Life Sciences N.V. analyst ratings, historical stock prices, earnings estimates & actuals. ATAI updated stock price target summary.Jul 10, 2023 · On July 10, 2023, the stock experienced a significant increase, driven by positive forecasts and a strong consensus among investment analysts. According to data from CNN Money, the 12-month price forecasts for ATAI stock have a median target of 11.00, with a high estimate of 21.00 and a low estimate of 6.00.

The company's stock is trading at about 20 cents per share as of Oct. 24. Cybin Inc . ( CYBN) Cybin, a Canadian psychedelic drug developer that produces treatments for depression, anxiety and ...

TipRanks | Stock Market Research, News and Analyst Forecasts - TipRanks.comAccording to 4 stock analysts, the average 12-month stock price forecast for ATAI stock stock is $13.5, which predicts an increase of 1,015.70%. The lowest …Web7 Wall Street research analysts have issued twelve-month price targets for Mind Medicine (MindMed)'s shares. Their MNMD share price targets range from $7.00 to $75.00. On average, they anticipate the company's share price to reach $25.43 in the next year. This suggests a possible upside of 684.8% from the stock's current price.Request a new password. showRSS is an internet tool that lets you keep track of your favorite TV shows.Some better-ranked stocks in the broader Medical space are Select Medical Holdings Corporation SEM, HCA Healthcare, Inc. HCA and Atai Life Sciences N.V. ATAI, each carrying a Zacks Rank #2 (Buy ...

According to the issued ratings of 1 analysts in the last year, the consensus rating for Arcadia Biosciences stock is Buy based on the current 1 buy rating for RKDA. The average twelve-month price prediction for Arcadia Biosciences is $15.00 with a high price target of $20.00 and a low price target of $10.00. Learn more on RKDA's analyst rating ...

ATAI Life Sciences N.V., a clinical-stage biopharmaceutical company, engages in acquiring, incubating, and developing various therapeutics to treat depression, anxiety, addiction, and other mental health disorders. Its principal clinical programs include RL-007, a pro-cognitive neuromodulator for cognitive impairment associated with ...

24. 3. 2023. ... ... predictions of future events. Although we believe that the ... Total stockholders' equity attributable to ATAI Life Sciences N.V. stockholders ...ADMA Stock 12 Months Forecast. $6.00. (51.90% Upside) Based on 2 Wall Street analysts offering 12 month price targets for ADMA Biologics in the last 3 months. The average price target is $6.00 with a high forecast of $7.00 and a low forecast of $5.00. The average price target represents a 51.90% change from the last price of $3.95.Stock Price Forecast. The 10 analysts offering 12-month price forecasts for Super Micro Computer Inc have a median target of 397.00, with a high estimate of 500.00 and a low estimate of 240.00 ... This influential firm issued a $20 share price target for ATAI, propelling its stock value to surge. As of May 24, 2023, ATAI Life Sciences boasts an average one-year price target of $13.75, as ...3:24 pm. Articles. atai Life Sciences Reports Second Quarter 2023 Financial Results and Operational Highlights, and Announces Clinical Data from the Phase 1 Study of DMX-1002 (Ibogaine) August 10, 2023 Advanced multiple clinical stage assets in development, including the on-going Phase 2b study of RL-007 in patients…. August 10, 2023.Find the latest ATAI Life Sciences N.V. ATAI analyst stock forecast, price target, and recommendation trends with in-depth analysis from research reports. Date Range. investment rating.Market cap is calculated by taking a company's price per share and multiplying it by the company's total number of shares outstanding. $214.15M. -60.0%. Market Cap / Employee. The market cap of a ...

Nov 18, 2022 · (See ATAI stock forecast on TipRanks) SomaLogic . The next Wood pick we’ll look at is a protein biomarker discovery and clinical diagnostics company. SomaLogic operates in what is known as the ... 06:48 PM ET 11/23/2020. Atai Life Sciences, a company that backs Compass Pathways ( CMPS) and other psychedelic drug developers, said Monday that it had closed a $125 million funding round, the ...NEW YORK and BERLIN, Sept. 14, 2023 (GLOBE NEWSWIRE) -- atai Life Sciences (NASDAQ: ATAI) (“atai”), a clinical-stage biopharmaceutical company aiming to transform the treatment of mental health disorders, will participate in the 2023 Cantor Fitzgerald Global Healthcare Conference. September 14, 2023. Press Release.Mar 31, 2023 · Atai Life Sciences ( ATAI 2.80%), a small-cap drugmaker developing psychedelic-based treatments for drug dependency and mental health disorders, posted strong gains during the first four days of ... Shares of the Peter Thiel -backed psychedelic start-up Atai Life Sciences jumped Friday on their first day of trading on Wall Street. The newly listed Nasdaq stock opened up 40% before pulling ...Down -34.59% in 4 Weeks, Here's Why You Should You Buy the Dip in atai Life Sciences N.V. (ATAI) Zacks - Tue Jan 31, 8:35AM CST . atai Life Sciences N.V. (ATAI) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earnings...

The highest rated platform for investors in the world! TipRanks is a comprehensive research tool that helps investors make better, data-driven investment decisions. TipRanks stock market research and analysis, lets you see the track record and measured performance of any analyst or blogger, so you know who to trust!CLLS Stock 12 Months Forecast. $6.33. (116.04% Upside) Based on 4 Wall Street analysts offering 12 month price targets for Cellectis SA in the last 3 months. The average price target is $6.33 with a high forecast of $10.00 and a low forecast of $3.00. The average price target represents a 116.04% change from the last price of $2.93.

Nov 27, 2023 · ATA Inc-China Stock Forecast and Price Target. If the average price target of $11.00 set by distinguished experts for ATA Inc-China over the past few weeks is reached this year, there would be a potential upside of approximately 900% from the last closing price in November, 2023. NEW YORK and BERLIN, Sept. 14, 2023 (GLOBE NEWSWIRE) -- atai Life Sciences (NASDAQ: ATAI) (“atai”), a clinical-stage biopharmaceutical company aiming to transform the treatment of mental health disorders, will participate in the 2023 Cantor Fitzgerald Global Healthcare Conference. September 14, 2023. Press Release.Being prepared to weather a hurricane — whether that involves fortifying your home or creating an emergency evacuation plan — is an important part of making it through the storm. Hurricanes travel across the ocean via massive, circular gust...Read an investment analysis of ATAI stock here. ... By 2029, it is forecast to be worth $7.2 billion globally, with a compound annual growth rate of 55%. Also, ...WebMarket Cap. $464.54M. Enterprise Value -$9.65M. Total Cash (Recent Filing) $474.19M. Total Debt (Recent Filing) $0.00. Price to Earnings (P/E) -3.5. Beta 1.92. Next Earnings. Mar 26, 2024.Jun 5, 2023 · ATAI stock closed at $1.76 and is up $0.10 during pre-market trading. Pre-market tends to be more volatile due to significantly lower volume as most investors only trade between standard trading hours. ATAI has a strong overall score of 70 meaning the stock holds a better value than 70% of stocks at its current price. Oct 24, 2023 · Ad. LendingTree. As we look ahead to 2024, some of the most promising AI-powered stock-picking platforms use natural language processing to generate actionable predictions. For example, EquBot ...

View a financial market summary for ATAI including stock price quote, trading volume, volatility, options volume, statistics, and other important company ...

NL0015000DX5. ATAI Life Sciences NV is a clinical-stage biopharmaceutical company. It engages in the treatment of mental health disorders. The company was founded by Christian Angermayer, Florian Brand, Srinivas Rao and Lars Christian Wilde in June 2018 and is headquartered in Berlin, Germany. Show more.

ATAI identifies promising mental health technologies or drugs and then acquires a stock interest, providing technical and financial support to hasten the time to market.Neogenomics Inc. () Stock Market info Recommendations: Buy or sell Neogenomics stock? Wall Street Stock Market & Finance report, prediction for the future: You'll find the Neogenomics share forecasts, stock quote and buy / sell signals below.According to present data Neogenomics's NEO shares and potentially its market environment have …Complete ATAI Life Sciences N.V. stock information by Barron's. View real-time ATAI stock price and news, along with industry-best analysis.ATA Inc-China Net Income Forecast for 2023 - 2025 - 2030. In the last year, ATA Inc-China has seen a decline in its Net Income, from $-169.84M to $-167.81M – a 1.20% decrease. In the next year, analysts predict that Net Income will reach $-169.84M – an increase of 1.21%. For the next nine years, the forecast is for Net Income to grow by 0.80%.Stock Price Forecast. The 4 analysts offering 12-month price forecasts for Somalogic Inc have a median target of 4.75, with a high estimate of 7.00 and a low estimate of 2.30. The median estimate ... On average, Wall Street analysts predict that Atai Life Sciences Nv 's share price could reach $17.50 by Aug 14, 2024. The average Atai Life Sciences Nv stock price prediction …WebA. While ratings are subjective and will change, the latest ATAI Life Sciences ( ATAI) rating was a reiterated with a price target of $0.00 to $20.00. The current price ATAI Life Sciences ( ATAI ...Find the latest Mind Medicine (MindMed) Inc. (MNMD) stock quote, history, news and other vital information to help you with your stock trading and investing.May 25, 2023 · These forecasts range from $9 to $20, indicating a considerable increase compared to its previous closing price of $1.88. Over the past 12 months, ATAI’s stock has witnessed a remarkable growth ... Atari S.A. is an interactive entertainment company and an iconic gaming industry brand that transcends generations and audiences. The company is globally recognized for its multi-platform, interactive entertainment and licensed products.

Are you tired of spending countless hours manually tracking your inventory? Are you looking for a way to improve your decision making and forecasting processes? Look no further than a free inventory tracking template.Nov 18, 2022 · (See ATAI stock forecast on TipRanks) SomaLogic . The next Wood pick we’ll look at is a protein biomarker discovery and clinical diagnostics company. SomaLogic operates in what is known as the ... According to the issued ratings of 4 analysts in the last year, the consensus rating for Atai Life Sciences stock is Buy based on the current 4 buy ratings for ATAI. The average twelve-month price prediction for Atai Life Sciences is $12.80 with a high price target of $20.00 and a low price target of $9.00. Learn more on ATAI's analyst rating ...RPHM. Reneo Pharmaceuticals Inc. 6.04. +0.10. +1.68%. Get ATAI Life Sciences NV (ATAI:NASDAQ) real-time stock quotes, news, price and financial information from CNBC.Instagram:https://instagram. dental insurance honolulusuccessful trading strategiesgrowth vs valuesucaf CLLS Stock 12 Months Forecast. $6.33. (116.04% Upside) Based on 4 Wall Street analysts offering 12 month price targets for Cellectis SA in the last 3 months. The average price target is $6.33 with a high forecast of $10.00 and a low forecast of $3.00. The average price target represents a 116.04% change from the last price of $2.93. Get the latest Mind Medicine (MindMed) Inc (MNMD) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions. susan b anthony 1979 worthbest dental insurance in florida 28.98. According to our current ATAI stock forecast, the value of Atai Life Sciences N.V. shares will drop by -18.90% and reach $ 0.875911 per share by December 3, 2023. …WebSee the latest Vista Energy SAB de CV ADR stock price (VIST:XNYS), related ... ATAI Life Sciences, LianBio, or BioXcel Therapeutics? PR Newswire Oct 26, 2023 ... value of 1964 kennedy half dollar proof Find real-time SMCI - Super Micro Computer Inc stock quotes, company profile, news and forecasts from CNN Business. A. While ratings are subjective and will change, the latest ATAI Life Sciences ( ATAI) rating was a reiterated with a price target of $0.00 to $20.00. The current price ATAI Life Sciences ( ATAI ...